CLINICAL_TRIALS
trial_result
· 2023-11-07
Clinical Trial Update: GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) [Phase 2]
Summary
Phase 2 trial update for GB002 in adults with pulmonary arterial hypertension has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | Conditions: Pulmonary Artery Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2023-11-07